BIONDVAX Trademark

Trademark Overview


On Tuesday, June 23, 2020, a trademark application was filed for BIONDVAX with the United States Patent and Trademark Office. The USPTO has given the BIONDVAX trademark a serial number of 79292511. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, May 5, 2021. This trademark is owned by BiondVax Pharmaceuticals Ltd.. The BIONDVAX trademark is filed in the Pharmaceutical Products category with the following description:

Influenza vaccines for human use
biondvax

General Information


Serial Number79292511
Word MarkBIONDVAX
Filing DateTuesday, June 23, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, May 5, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesInfluenza vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, August 29, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameScinai Immunotherapeutics Ltd.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressIL

Party NameBiondVax Pharmaceuticals Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIL

Trademark Events


Event DateEvent Description
Wednesday, September 2, 2020APPLICATION FILING RECEIPT MAILED
Thursday, August 27, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB
Saturday, August 29, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 25, 2020ASSIGNED TO EXAMINER
Thursday, October 1, 2020NON-FINAL ACTION WRITTEN
Friday, October 2, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sunday, February 20, 2022NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Thursday, May 5, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, October 22, 2020REFUSAL PROCESSED BY MPU
Thursday, October 22, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, November 9, 2020REFUSAL PROCESSED BY IB
Wednesday, May 5, 2021ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, May 5, 2021ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, February 2, 2022NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, February 2, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, May 5, 2022FINAL DISPOSITION NOTICE SENT TO IB
Thursday, July 18, 2024CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, May 24, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, February 3, 2024NEW REPRESENTATIVE AT IB RECEIVED

Related Keywords


biondvax human vaccines influenza